New drug RAB001 takes first step: safety check in healthy volunteers
NCT ID NCT07545018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety and tolerability of a new drug called RAB001 in 16 healthy adults. Researchers gave single and multiple injections at two dose levels to see how the body handles the drug and if it causes side effects. This is a first step before testing the drug in people with osteonecrosis of the femoral head.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEONECROSIS OF THE FEMORAL HEAD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hebei University Affiliated Hospital
Baoding, Hebei, 071000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stem cells and oxygen therapy may save hips from collapse
- Blood test could catch hip disease before It's too late
- New combo treatment aims to save hips from collapse
- New drug aims to stop hip bone death from steroids
- Could your own bone marrow cells save your hip from collapse?
- New combo nerve block may ease hip surgery pain better